TN
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation | BMC molecular and cell biology | 2022 | 19 | 3 | |||
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol | BMJ open | 2022 | 18 | 20 | |||
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | 2022 | 238 | 148 | |||
Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls | Journal of pediatric hematology/oncology | 2021 | 228 | 0 | |||
Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT | Bone marrow transplantation | 2021 | 201 | 2 | |||
ABO incompatibile graft management in pediatric transplantation | Bone marrow transplantation | 2021 | 156 | 1 | |||
Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) | Frontiers in pediatrics | 2021 | 259 | 81 | |||
Genetic Predictors for Sinusoidal Obstruction Syndrome - A Systematic Review | Journal of personalized medicine | 2021 | 201 | 79 | |||
The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports | 2021 | 209 | 95 | |||
Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland | BMC Medical research methodology | 2021 | 192 | 91 | |||
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study | CPT: pharmacometrics & systems pharmacology | 2021 | 186 | 83 | |||
Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2020 | 275 | 0 | |||
The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review | International Journal of Molecular Sciences | 2019 | 281 | 166 | |||
Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary? | Platelets | 2018 | 290 | 0 | |||
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation | British Journal of Clinical Pharmacology | 2018 | 295 | 116 | |||
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2017 | 427 | 17 | |||
GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | 2017 | 449 | 176 |